USPTO trademark

XTAP

Under examinationUSPTOWord markClass 5

"XTAP" is a word mark owned by Crosslink Therapeutics Inc., filed at the USPTO on June 15, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Official USPTO record
XTAP trademark as filed
As filed with the USPTO
Status
Under examination
Since September 28, 2026
Filed
June 15, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99884968
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns XTAP

The owner and representative on file with the office.

Owner

Crosslink Therapeutics Inc.

Boston, United States

Representative

Alexandria P Stiteler

Hoffmann & Baron, LLP

Goods and services

What the mark covers

The products and services XTAP is filed for, grouped by Nice class.

  • Biological preparations for the treatment of immunological and oncological conditions and diseases; Therapeutic biological preparations for use in Immunology and immuno-oncology

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. Application filing receipt mailed
  6. New application office supplied data entered
  7. New application entered
FAQ

About XTAP

Who owns the trademark "XTAP"?

The USPTO trademark "XTAP" (application 99884968) is owned by Crosslink Therapeutics Inc.

What is the status of "XTAP"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull XTAP and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019ed402-9115-7323-a02a-2f37f5ad66a6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019ed402-9115-7323-a02a-2f37f5ad66a6",
  "object": "trademark",
  "mark_text": "XTAP",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99884968",
  "filing_date": "2026-06-15",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Crosslink Therapeutics Inc.",
      "entity_id": null
    }
  ]
}